𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations

✍ Scribed by Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C. Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
505 KB
Volume
24
Category
Article
ISSN
0192-8651

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Molecular mechanics models have been applied extensively to study the dynamics of proteins and nucleic acids. Here we report the development of a third‐generation point‐charge all‐atom force field for proteins. Following the earlier approach of Cornell et al., the charge set was obtained by fitting to the electrostatic potentials of dipeptides calculated using B3LYP/cc‐pVTZ//HF/6‐31G** quantum mechanical methods. The main‐chain torsion parameters were obtained by fitting to the energy profiles of Ace‐Ala‐Nme and Ace‐Gly‐Nme di‐peptides calculated using MP2/cc‐pVTZ//HF/6‐31G** quantum mechanical methods. All other parameters were taken from the existing AMBER data base. The major departure from previous force fields is that all quantum mechanical calculations were done in the condensed phase with continuum solvent models and an effective dielectric constant of ε = 4. We anticipate that this force field parameter set will address certain critical short comings of previous force fields in condensed‐phase simulations of proteins. Initial tests on peptides demonstrated a high‐degree of similarity between the calculated and the statistically measured Ramanchandran maps for both Ace‐Gly‐Nme and Ace‐Ala‐Nme di‐peptides. Some highlights of our results include (1) well‐preserved balance between the extended and helical region distributions, and (2) favorable type‐II poly‐proline helical region in agreement with recent experiments. Backward compatibility between the new and Cornell et al. charge sets, as judged by overall agreement between dipole moments, allows a smooth transition to the new force field in the area of ligand‐binding calculations. Test simulations on a large set of proteins are also discussed. © 2003 Wiley Periodicals, Inc. J Comput Chem 24: 1999–2012, 2003


📜 SIMILAR VOLUMES


Force-field modeling through quantum mec
✍ Ivo Cacelli; Carlo Federico Lami; Giacomo Prampolini 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

## Abstract Interaction energy of the 4‐__n__‐pentyloxy‐4′‐cyanobiphenyl (5OCB) dimer is computed at MP2 level, for many geometrical arrangements using the Fragmentation Reconstruction Method (FRM). DFT calculations are performed for a number of geometries of the monomer. The resulting database is

Optimization of a molecular mechanics fo
✍ Blandine Courcot; Adam J. Bridgeman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract A stochastic technique based on genetic algorithms was implemented to develop new force fields by optimizing molecular mechanics (MM) parameters. These force fields have been optimized for inorganic compounds such as polyoxometalates (POMs) and especially for type‐I polymolybdate and po

Extending the treatment of backbone ener
✍ Alexander D. Mackerell Jr.; Michael Feig; Charles L. Brooks III 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB

## Abstract Computational studies of proteins based on empirical force fields represent a powerful tool to obtain structure–function relationships at an atomic level, and are central in current efforts to solve the protein folding problem. The results from studies applying these tools are, however,

Chain conformation in polyretropeptides.
✍ Carlos Alemán; Jordi Puiggalí 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 885 KB

A conformational study of the terpolymer of glycine and its retropeptides monomethylendiamine (gGly) and malonyl (mGly) with sequence: (-Gly-gGly-mGly-), is presented. First, we investigated the conformational preferences of the model molecule 2,5,9,11-tetraoxo-3,6,8,12-tetraza-tridecane using quant